Showing results (31-40 of 689) with videos related to
Sort By:
Pageof 69
The Journal of Antimicrobial Chemotherapy|June 1, 1995
Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patientsJ L Rodríguez-Tudela, J V Martínez-Suárez, F Dronda, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1997
Clinical significance of splenic tuberculosis in patients infected with human immunodeficiency virusA González-López, F Dronda, M Alonso-Sanz, et al.Revista Clinica Espanola|January 1, 1996
[Campylobacter jejuni infections in a prison population coinfected with the human immunodeficiency virus]J I Fernández-Martín, F Dronda, F Chaves, et al.Enfermedades Infecciosas Y Microbiologia Clinica|February 1, 1996
[Primary cutaneous cryptococcosis and bacterial pneumonia caused by Pseudomonas aeruginosa in AIDS: clinical case and review of the literature]F Dronda, A González-López, J I Fernández-Martín, et al.Medicina Clinica|January 28, 1995
[Resistant tuberculosis in a prison population during 1991-1993]F Chaves, F Dronda, A Ortega, et al.Reviews of Infectious Diseases|January 1, 1990
Capnophilic and anaerobic bacteremia in neutropenic patients: an oral sourceF Baquero, J Fernández, F Dronda, et al.The American Journal of Pathology|December 19, 2009
The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathwaysCarlos S MorenoAntiviral Therapy|May 7, 2003
Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patientsJ L Casado, R Sabido, M J Perez-Elías, et al.AIDS (London, England)|August 26, 1998
Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patientsJ L Casado, M J Perez-Elías, A Antela, et al.Pageof 69